相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Intrinsic Hydrophobicity Scale for Amino Acids and Its Application to Fluorinated Compounds
Waldemar Hoffmann et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential
Mohammad Seyedabadi et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fabio Madeira et al.
NUCLEIC ACIDS RESEARCH (2019)
Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic Efficacy
Michael M. Miller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Toward Defining the Pharmacophore for Positive Allosteric Modulation of PTH1 Receptor Signaling by Extracellular Nucleotides
Brandon H. Kim et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2019)
Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics
Benjamin E. Tourdot et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
Gamariel Rwibasira Rudinga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram et al.
MOLECULAR PHARMACOLOGY (2018)
Structure and dynamics of GPCR signaling complexes
Daniel Hilger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Structure and dynamics of GPCR signaling complexes
Daniel Hilger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Structural Basis for G Protein-Coupled Receptor Signaling
Sarah C. Erlandson et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 47 (2018)
PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
Simon J. Wilson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms
Pierre-Yves Jean-Charles et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family
Michael J. Woolley et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
Rithwik Ramachandran et al.
MOLECULAR PHARMACOLOGY (2017)
Structural insight into allosteric modulation of protease-activated receptor 2
Robert K. Y. Cheng et al.
NATURE (2017)
Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand
I. C. Moschonas et al.
PLATELETS (2017)
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
Pancras C. Wong et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets
Daniel Sanchez Centellas et al.
THROMBOSIS RESEARCH (2017)
Protease-activated receptor 4: from structure to function and back again
Shauna L. French et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency
Peter Chidiac
METHODS (2016)
GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization
Hasup Lee et al.
NUCLEIC ACIDS RESEARCH (2015)
Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race
Leonard C. Edelstein et al.
BLOOD (2014)
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease
M. D. Hollenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The Physical Association of the P2Y12 Receptor with PAR4 Regulates Arrestin-Mediated Akt Activation
Aasma Khan et al.
MOLECULAR PHARMACOLOGY (2014)
Molecular signatures of G-protein-coupled receptors
A. J. Venkatakrishnan et al.
NATURE (2013)
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu et al.
NATURE BIOTECHNOLOGY (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Lifting the lid on GPCRs: the role of extracellular loops
M. Wheatley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
Benjamin M. Scirica et al.
LANCET (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets
Dongjun Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Potent Agonists of the Protease Activated Receptor 2 (PAR2)
Scott Boitano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
Fabian Sievers et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Structure, function and pathophysiology of protease activated receptors
Mark N. Adams et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Signal transduction by protease-activated receptors
Unice J. K. Soh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial
David A. Morrow et al.
AMERICAN HEART JOURNAL (2009)
Protease-Activated Receptor 4 Uses Anionic Residues To Interact with α-Thrombin in the Absence or Presence of Protease-Activated Receptor 1
Marvin T. Nieman
BIOCHEMISTRY (2008)
Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site
Marvin T. Nieman et al.
BIOCHEMISTRY (2007)
PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation
Michael Holinstat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis
AJ Leger et al.
CIRCULATION (2006)
Protease-activated receptors in hemostasis, thrombosis and vascular biology
SR Coughlin
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
The repertoire of G-protein-coupled receptors in fully sequenced genomes
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2005)
PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations
TJ Dolinsky et al.
NUCLEIC ACIDS RESEARCH (2004)
A novel Gαq/11-selective inhibitor
J Takasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage
SL Jacques et al.
BIOCHEMICAL JOURNAL (2003)
Proteinase-activated receptors: Tethered ligands and receptor-activating peptides
MD Hollenberg
DRUG DEVELOPMENT RESEARCH (2003)
Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation
L Covic et al.
NATURE MEDICINE (2002)
Seven-transmembrane receptors
KL Pierce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Proteinase-activated receptor 2: Differential activation of the receptor by tethered ligand and soluble peptide analogs
B Al-Ani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Substrate-assisted catalysis of the PAR1 thrombin receptor - Enhancement of macromolecular association and cleavage
SL Jacques et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin
MJ Shapiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
YD-3, a novel inhibitor of protease-induced platelet activation
CC Wu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Structure-function analysis of protease-activated receptor 4 tethered ligand peptides - Determinants of specificity and utility in assays of receptor function
TR Faruqi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
